Oncimmune to publish full year results on 30th October 2020

Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, will be announcing its full year results for the year ended 31 May 2020 on Friday, 30 October 2020.

Adam Hill, Chief Executive Officer, together with Matthew Hall, Chief Financial Officer, will host a presentation and conference call for analysts at 11:30am GMT on the day of the results.

For conference call details please contact Alexander Davis of FTI Consulting at Alexander.Davis@fticonsulting.com or 020 3727 1000.

The management team will also host on Investor Meet Company a live presentation of the results on Friday, 30 October at 15:00 GMT.

•     The online presentation will be open to all existing shareholders and potential new investors.

•     Questions can be submitted before the event via your Investor Meet Company dashboard or at any time during the live presentation via the “Ask a Question” function. Responses to the Q&A will be published at the earliest opportunity on the Investor Meet Company platform.

•     Investor feedback can also be submitted directly to management immediately following the event.

Access to Investor Meet Company is free and interested parties can register to attend the presentation via the following link: https://www.investormeetcompany.com/essensys-plc/register-investor 

Attendees who have already registered on the Investor Meet Company platform to meet the Company will automatically receive an invitation to the presentation.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn

    More articles like this

    Oncimmune Holdings PLC

    UK biotechs seek to speed up cancer detection

    When top cancer doctors gathered for the annual meeting of the American Society of Clinical Oncology last weekend, faster detection of the illness was on medics’ minds. Nottingham-based Oncimmune, listed on Aim, has developed a patented

    Oncimmune Holdings PLC

    Oncimmune Holdings plc EarlyCDT®-Lung Registered in Columbia

    Oncimmune Holdings plc (LON: ONC), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announced its distributor in Columbia, Valentech International LLC, has obtained regulatory

    Oncimmune Holdings PLC

    Cancer symptoms: Does your voice sound like this?

    Cancer symptoms are not always obvious and can sometimes go undetected, so it’s important to be unaware of any unexplained changes to your body. If you notice your voice sounding like this, see a doctor as

    Oncimmune Holdings PLC

    Eating Tomatoes to Fight Liver Cancer

    In the fight against cancer, there is a surprising tool in the arsenal: the food we eat. That is because some nutrients in food have been found to play a role in preventing cancer, and it

    Oncimmune Holdings PLC

    Whole grains might help ward off liver cancer

    Yet another benefit of eating a diet containing high amounts of whole grains may be a reduced risk of liver cancer, a new U.S. study suggests. The analysis of data on more than 125,000 men and